Cargando…

Organoid Models for Precision Cancer Immunotherapy

Cancer immunotherapy is exploited for the treatment of disease by modulating the immune system. Since the conventional in vivo animal and 2D in vitro models insufficiently recapitulate the complex tumor immune microenvironment (TIME) of the original tumor. In addition, due to the involvement of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Cai-Ping, Lan, Huan-Rong, Fang, Xing-Liang, Yang, Xiao-Yun, Jin, Ke-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016193/ https://www.ncbi.nlm.nih.gov/pubmed/35450073 http://dx.doi.org/10.3389/fimmu.2022.770465

Ejemplares similares

Cancer organoid co-culture model system: Novel approach to guide precision medicine
por: Yuan, Jin, et al.
Publicado: (2023)

Breast cancer organoids and their applications for precision cancer immunotherapy
por: Guan, Dandan, et al.
Publicado: (2023)

Precision Immunotherapy for Sepsis
por: Peters van Ton, Annemieke M., et al.
Publicado: (2018)

Application of organoids in precision immunotherapy of lung cancer (Review)
por: Tian, Huichuan, et al.
Publicado: (2023)

Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?
por: Tran, Florian, et al.
Publicado: (2020)

Commentary: Precision Immunotherapy for Sepsis
por: Zijlstra, Jan G., et al.
Publicado: (2019)

Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer
por: Chen, Yukun, et al.
Publicado: (2023)

Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
por: Zhao, Qijie, et al.
Publicado: (2021)

Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
por: Wang, Bingran, et al.
Publicado: (2022)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Intersection of nanomaterials and organoids technology in biomedicine
por: Shen, Chen, et al.
Publicado: (2023)

Organoid modeling for cancer precision medicine
por: Cantrell, Michael A, et al.
Publicado: (2015)

Immunological Classification of Tumor Types and Advances in Precision Combination Immunotherapy
por: Ren, Xiufang, et al.
Publicado: (2022)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Multiplexed engineering and precision gene editing in cellular immunotherapy
por: Biederstädt, Alexander, et al.
Publicado: (2022)

Patient-Derived Tumor Organoids: New Progress and Opportunities to Facilitate Precision Cancer Immunotherapy
por: Wang, Ji, et al.
Publicado: (2022)

Proteomics and Organoid Culture Reveal the Underlying Pathogenesis of Hashimoto’s Thyroiditis
por: Xiao, Hui, et al.
Publicado: (2021)

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
por: Zhou, Huijie, et al.
Publicado: (2023)

Crosstalk of four kinds of cell deaths defines subtypes of cutaneous melanoma for precise immunotherapy and chemotherapy
por: Wan, Qi, et al.
Publicado: (2022)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
por: Cai, Zhiyong, et al.
Publicado: (2022)

Can immunotherapy reinforce chemotherapy efficacy? a new perspective on colorectal cancer treatment
por: He, Xing, et al.
Publicado: (2023)

Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
por: Alfarra, Helmi, et al.
Publicado: (2020)

Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines
por: Holay, Namit, et al.
Publicado: (2017)

Human Immune System Mice With Autologous Tumor for Modeling Cancer Immunotherapies
por: Sun, Liguang, et al.
Publicado: (2020)

Application of a JEG-3 organoid model to study HLA-G function in the trophoblast
por: Zhuang, Bai-Mei, et al.
Publicado: (2023)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
por: Burger, Michael C., et al.
Publicado: (2019)

Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications
por: Fang, Pinhao, et al.
Publicado: (2022)

Human Brain Organoids as an In Vitro Model System of Viral Infectious Diseases
por: Su, Xuan, et al.
Publicado: (2022)

Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
por: Yang, Chang, et al.
Publicado: (2019)

Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification
por: Chen, Yi, et al.
Publicado: (2022)

Applying Precision Medicine and Immunotherapy Advances from Oncology to Host-Directed Therapies for Infectious Diseases
por: Mahon, Robert N., et al.
Publicado: (2017)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

Tumor organoids: applications in cancer modeling and potentials in precision medicine
por: Xu, Hanxiao, et al.
Publicado: (2022)

Lung cancer organoids: models for preclinical research and precision medicine
por: Liu, Yajing, et al.
Publicado: (2023)

Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy
por: Jiang, Ying, et al.
Publicado: (2023)

Organoids and microphysiological systems: Promising models for accelerating AAV gene therapy studies
por: Ramamurthy, Ritu Mahesh, et al.
Publicado: (2022)

It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
por: Yao, Shiya, et al.
Publicado: (2023)

Bibliometric Analysis of Chimeric Antigen Receptor-Based Immunotherapy in Cancers From 2001 to 2021
por: Ou, Zhanpeng, et al.
Publicado: (2022)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7janj3eq8t1kft6v6karigsg6c